Pedro M. Rodrigues

机构：Ikerbasque, University of the Basque Country, Instituto de Salud Carlos III, Biogipuzkoa Health Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Onkologikoa, Fraunhofer Portugal Research, Universidad de Navarra · ORCID：0000-0001-6193-7436

发表论文 149 篇 · 总被引 7552 次 · h-index 37

代表论文

• Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) (2024 · Atherosclerosis · 被引 80)
• New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas (2025 · Journal of Hepatology · 被引 14)
• Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk (2025 · Hepatology · 被引 12)
• Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries’ framework for digital twin advancement (2025 · Hepatology · 被引 6)
• Cortical Thymic Epithelial Cells: Key Developers of the Code of T‐Cell Selection and TCR Repertoire Diversity (2025 · Immunological Reviews · 被引 5)
• Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes (2024 · The Lancet Regional Health - Americas · 被引 4)